5-?á?á(2,3-Difluorophenyl)methyl?åthio?å-7-?á?á2-hydroxy-1-(hydroxymethyl)-1-methylethyl?åamino?åthiazolo?á4,5-d?åpyrimidin-2(3H)-one monosodium salt as CXCR2 antagonist

5-?á?á(2,3-Difluorophenyl)methyl?åthio?å-7-?á?á2-hydroxy-1-(hydroxymethyl)-1-methylethyl?åamino?åthiazolo?á4,5-d?åpyrimidin-2(3H)-one monosodium salt as CXCR2 antagonist

A compound of formula (I) and pharmaceutically acceptable salts or solvates thereof for use in therapy.

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: BONNERT ROGER VICTOR D
Format: Patent
Sprache:eng ; slv
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A compound of formula (I) and pharmaceutically acceptable salts or solvates thereof for use in therapy.